1. Home
  2. DPG vs BVS Comparison

DPG vs BVS Comparison

Compare DPG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duff & Phelps Utility and Infrastructure Fund Inc.

DPG

Duff & Phelps Utility and Infrastructure Fund Inc.

HOLD

Current Price

$14.74

Market Cap

535.3M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$9.97

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DPG
BVS
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
535.3M
617.1M
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
DPG
BVS
Price
$14.74
$9.97
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.00
AVG Volume (30 Days)
78.5K
410.7K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
163.46
EPS
N/A
0.33
Revenue
N/A
$568,087,000.00
Revenue This Year
N/A
$7.52
Revenue Next Year
N/A
$7.06
P/E Ratio
N/A
$28.56
Revenue Growth
N/A
N/A
52 Week Low
$11.60
$5.81
52 Week High
$15.15
$9.53

Technical Indicators

Market Signals
Indicator
DPG
BVS
Relative Strength Index (RSI) 56.11 69.02
Support Level $14.04 $8.43
Resistance Level $14.81 N/A
Average True Range (ATR) 0.25 0.35
MACD 0.02 0.05
Stochastic Oscillator 57.63 100.00

Price Performance

Historical Comparison
DPG
BVS

About DPG Duff & Phelps Utility and Infrastructure Fund Inc.

Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund, and its objective is to seek total return, derived mainly from a high level of current income, with an emphasis on providing tax-advantaged dividend income and growth in current income, and secondarily from capital appreciation.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: